Rare infectious diseases face unique challenges in terms of diagnosis. Our company has always been at the forefront of diagnostic solutions for such illnesses. By leveraging advanced technologies in point-of-care diagnostics, we develop customized antigen and microbial detection reagents/kits for rare infectious diseases, facilitating early identification of pathogens and rapid control of infections.
Overview of Infectious Diseases
Rare infectious diseases encompass a diverse group of illnesses caused by pathogens such as bacteria, viruses, parasites, and fungi. These conditions are characterized by their low incidence rate, making them particularly challenging to diagnose effectively. Below are some of the challenges facing rare infectious disease diagnostics.
Laboratory Testing Limitations
Specialized laboratories capable of diagnosing rare infectious diseases may not be readily available in all geographic regions, leading to delays in obtaining accurate test results.
Differential Diagnosis Challenges
Rare infectious diseases may share symptoms with more prevalent conditions, making it challenging to differentiate between the two without targeted diagnostic testing.
Emerging Pathogens
The rapid mutation of pathogens, coupled with the issue of antibiotic resistance, leads to the swift evolution of sources of infection, posing challenges to accurate diagnosis.
Market Analysis of Infectious Disease Diagnostics
In 2022, the infectious disease diagnostic market size was $24 billion. It is projected that the compound annual growth rate from 2023 to 2032 will exceed 5.5%. The increasing popularity of point-of-care diagnostic testing will drive industry growth.
Fig. 1 Flow diagram showing the process of sample testing using point-of care devices. (Nath P, et al., 2020)
Point-of-care Diagnostic Development for Infectious Diseases
Point-of-care (POC) diagnostics are medical tests performed at or near the point of patient care. These tests are designed to provide rapid results, enabling immediate clinical decisions for patients. POC diagnostics contribute to early detection of rare infectious diseases, playing a crucial role in timely interventions for diseases and epidemic control.
Rapid Antigen Tests
These tests detect the presence of specific proteins (antigens) on the surface of pathogens, such as viruses or bacteria, providing quick results for infections like influenza or COVID-19.
Lab-on-a-Chip Devices
Microfluidic devices that integrate multiple laboratory functions on a single chip, enabling rapid and automated sample processing for various diagnostic applications.
Lateral Flow Assays
These tests detect the presence of a target analyte in a sample using capillary action, commonly used for rapid detection of biomarkers, antibodies, or pathogens.
Our Services
Our company is dedicated to driving innovation in rare infectious disease diagnostic development, addressing unmet diagnostic needs, and advancing precision medicine. We specialize in designing antigen and microbial detection reagents/kits tailored for rare infectious diseases. By integrating technologies related to point-of-care diagnostics, we are able to offer portable and user-friendly diagnostic products for the rapid diagnosis of rare infectious diseases, thereby enhancing diagnostic efficiency and accuracy.
Types of Rare Infectious Diseases
| A-D |
| Acinetobacter Infection |
Chikungunya |
| Acquired Immune Deficiency Syndrome (AIDS) |
Chlamydia |
| Actinomycosis |
Chlamydia Infection |
| Adenovirus Infection |
Clostridioides Difficile Infection |
| African Trypanosomiasis |
Coronavirus Disease 2019 (COVID-19) |
| Amoebiasis |
Creutzfeldt-Jakob Disease (CJD) |
| Angiostrongyliasis |
Crimean-Congo Hemorrhagic Fever (CCHF) |
| Anthrax |
Cryptococcosis |
| Brucellosis |
Cryptosporidiosis |
| Burkholderia Infection |
Cytomegalovirus Infection |
| Buruli Ulcer |
Dengue Fever |
| Chagas Disease |
Dientamoebiasis |
| Chickenpox |
Diphtheria |
| E-H |
| Ebola Virus Disease (EVD) |
Hantavirus Pulmonary Syndrome |
| Echinococcosis |
Heartland Virus Disease |
| Ehrlichiosis |
Helicobacter Pylori |
| Enterococcus Infection |
Hemolytic-uremic Syndrome (HUS) |
| Enterovirus Infection |
Hemorrhagic Fever with Renal Syndrome (HFRS) |
| Epidemic Typhus |
Hendra Virus Infection |
| Epstein–Barr Virus Infectious Mononucleosis |
Hepatitis |
| Fasciolasis |
Herpes Simplex |
| Glanders |
Histoplasmosis |
| Gonorrhea |
Hookworm Infection |
| Group A Streptococcal Infection (GAS Infection) |
Human Papillomavirus Infection |
| Haemophilus Influenzae Infection |
Human T-Lymphotropic Virus Type 1 (HTLV-1) |
| Hand, Foot and Mouth Disease (HFMD) |
Hymenolepiasis |
| I-N |
| Invasive Aspergillosis |
Marburg Hemorrhagic Fever (MHF) |
| Isosporiasis |
Marburg Virus Disease |
| Japanese Encephalitis |
Measles |
| Kingella Kingae Infection |
Melioidosis |
| Kuru |
Meningitis |
| Lassa Fever |
Meningococcal Disease |
| Legionellosis |
Metagonimiasis |
| Leishmaniasis |
Microsporidiosis |
| Leprosy |
Middle East Respiratory Syndrome (MERS) |
| Leptospirosis |
Mycoplasma Pneumoniae Infection |
| Lyme Disease |
Neonatal Conjunctivitis |
| Lymphatic Filariasis |
Nipah Virus Infection |
| Lymphocytic Choriomeningitis |
Nocardiosis |
| Malaria |
Norovirus |
| O-Z |
| Pertussis (Whooping Cough) |
Sporotrichosis |
| Plague |
Streptococcal Infections |
| Pneumococcal Infection |
Syphilis |
| Poliomyelitis |
Taeniasis |
| Psittacosis |
Tetanus |
| Q Fever |
Toxoplasmosis |
| Rabies |
Trachoma |
| Respiratory Syncytial Virus Infection |
Trichomoniasis |
| Rift Valley Fever |
Tuberculosis |
| Rotavirus Infection |
Typhoid Fever |
| Rubella |
West Nile Virus |
| Salmonellosis |
Yellow Fever |
| Schistosomiasis |
Yersinia Pseudotuberculosis Infection |
| Severe Acute Respiratory Syndrome (SARS) |
Zika Fever |
To achieve precision treatment for rare infectious diseases, we provide companion diagnostic development services. These services can help identify the most effective treatment options for patients by analyzing specific biomarkers or genetic markers associated with the disease.
If you are interested in our services, please feel free to contact us for more details and quotation information of related services.
References
- Nath P, Kabir A, Khoubafarin Doust S, et al. Detection of bacterial and viral pathogens using photonic point-of-care devices[J]. Diagnostics, 2020, 10(10): 841.
- Wang C, Liu M, Wang Z, et al. Point-of-care diagnostics for infectious diseases: From methods to devices[J]. Nano Today, 2021, 37: 101092.
All of our services and products are intended for preclinical research use
only and cannot be used to diagnose, treat or manage patients.
